{"id":46189,"date":"2022-07-14T17:01:55","date_gmt":"2022-07-14T15:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/"},"modified":"2022-07-14T17:01:55","modified_gmt":"2022-07-14T15:01:55","slug":"global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/","title":{"rendered":"Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5525881\/congenital-diarrheal-disorders-epidemiology?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=wzgclb&amp;utm_campaign=1726414+-+Global+Congenital+Diarrheal+Disorders+Epidemiology+Forecasts+to+2032&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Congenital Diarrheal Disorders &#8211; Epidemiology Forecast to 2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220714005650\/en\/1514185\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220714005650\/en\/1514185\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report delivers an in-depth understanding of the disease, historical and forecasted Congenital Diarrheal Disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.\n<\/p>\n<p>\n<strong>Geographies Covered<\/strong>\n<\/p>\n<ul>\n<li>\nThe United States\n<\/li>\n<li>\nEU5 (Germany, France, Italy, Spain, and the United Kingdom)\n<\/li>\n<li>\nJapan\n<\/li>\n<\/ul>\n<p>\n<strong>Study Period:<\/strong> 2019-2032\n<\/p>\n<p>\n<strong>Congenital Diarrheal Disorders Understanding<\/strong>\n<\/p>\n<p>\nThe Congenital Diarrheal Disorders epidemiology report gives a thorough understanding of the Congenital Diarrheal Disorders by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Congenital Diarrheal Disorders in the US, Europe, and Japan. The report covers the detailed information of the Congenital Diarrheal Disorders epidemiology scenario in seven major countries (US, EU5, and Japan).\n<\/p>\n<p>\n<strong>Congenital Diarrheal Disorders Epidemiology Perspective<\/strong>\n<\/p>\n<p>\nThe Congenital Diarrheal Disorders epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Congenital Diarrheal Disorders epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Congenital Diarrheal Disorders epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.\n<\/p>\n<p>\n<strong>Congenital Diarrheal Disorders Detailed Epidemiology Segmentation<\/strong>\n<\/p>\n<p>\nThe Congenital Diarrheal Disorders epidemiology covered in the report provides historical as well as forecasted Congenital Diarrheal Disorders epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.\n<\/p>\n<p>\nThe Congenital Diarrheal Disorders report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.\n<\/p>\n<p>\n<strong>Scope of the Report<\/strong>\n<\/p>\n<ul>\n<li>\nThe Congenital Diarrheal Disorders report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns\n<\/li>\n<li>\nThe Congenital Diarrheal Disorders Epidemiology Report and Model provide an overview of the global trends of Congenital Diarrheal Disorders in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)\n<\/li>\n<li>\nThe report provides insight into the historical and forecasted patient pool of Congenital Diarrheal Disorders in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan\n<\/li>\n<li>\nThe report helps recognize the growth opportunities in the 7MM for the patient population\n<\/li>\n<li>\nThe report assesses the disease risk and burden and highlights the unmet needs of Congenital Diarrheal Disorders\n<\/li>\n<li>\nThe report provides the segmentation of the Congenital Diarrheal Disorders epidemiology\n<\/li>\n<\/ul>\n<p>\n<strong>Report Highlights<\/strong>\n<\/p>\n<ul>\n<li>\n11-year Forecast of Congenital Diarrheal Disorders epidemiology\n<\/li>\n<li>\n7MM Coverage\n<\/li>\n<li>\nPrevalent and Diagnosed Cases of Congenital Diarrheal Disorders\n<\/li>\n<li>\nCases of Congenital Diarrheal Disorders by Mutation Types\n<\/li>\n<li>\nCongenital Diarrheal Disorders Cases associated with Clinical Manifestations\n<\/li>\n<\/ul>\n<p>\n<strong>KOL views<\/strong>\n<\/p>\n<p>\nThe publisher interviews, KOLs and SME&#8217;s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.\n<\/p>\n<p>\n<strong>Key Questions Answered<\/strong>\n<\/p>\n<ul>\n<li>\nWhat will be the growth opportunities in the 7MM with respect to the patient population pertaining to Congenital Diarrheal Disorders?\n<\/li>\n<li>\nWhat are the key findings pertaining to the Congenital Diarrheal Disorders epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?\n<\/li>\n<li>\nWhat would be the total number of patients of Congenital Diarrheal Disorders across the 7MM during the forecast period (2019-2032)?\n<\/li>\n<li>\nAmong the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?\n<\/li>\n<li>\nAt what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?\n<\/li>\n<li>\nWhat is the disease risk, burden and unmet needs of Congenital Diarrheal Disorders?\n<\/li>\n<li>\nWhat are the currently available treatments of Congenital Diarrheal Disorders?\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to Buy<\/strong>\n<\/p>\n<p>\nThe Congenital Diarrheal Disorders Epidemiology report will allow the user to &#8211;\n<\/p>\n<ul>\n<li>\nDevelop business strategies by understanding the trends shaping and driving the global Congenital Diarrheal Disorders market\n<\/li>\n<li>\nQuantify patient populations in the global Congenital Diarrheal Disorders market to improve product design, pricing, and launch plans\n<\/li>\n<li>\nOrganize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Congenital Diarrheal Disorders therapeutics in each of the markets covered\n<\/li>\n<li>\nUnderstand the magnitude of Congenital Diarrheal Disorders population by its epidemiology\n<\/li>\n<li>\nThe Congenital Diarrheal Disorders Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5525881\/congenital-diarrheal-disorders-epidemiology?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=wzgclb&amp;utm_campaign=1726414+-+Global+Congenital+Diarrheal+Disorders+Epidemiology+Forecasts+to+2032&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/n3ni4z<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#112;&#x72;&#x65;s&#115;&#x40;r&#101;&#x73;&#x65;a&#114;&#x63;h&#97;&#x6e;&#x64;&#109;&#97;&#x72;k&#101;&#x74;&#x73;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#x73;s&#64;&#x72;&#101;&#x73;e&#97;&#x72;&#99;&#x68;a&#x6e;&#x64;&#109;&#x61;r&#x6b;e&#116;&#x73;&#46;&#x63;o&#109;<\/a>\n<\/p>\n<p>\nFor E.S.T. Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Congenital Diarrheal Disorders &#8211; Epidemiology Forecast to 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the disease, historical and forecasted Congenital Diarrheal Disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered The United &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46189","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Congenital Diarrheal Disorders &#8211; Epidemiology Forecast to 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the disease, historical and forecasted Congenital Diarrheal Disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered The United ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-14T15:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220714005650\/en\/1514185\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-14T15:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/\"},\"wordCount\":877,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005650\\\/en\\\/1514185\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/\",\"name\":\"Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005650\\\/en\\\/1514185\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-14T15:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005650\\\/en\\\/1514185\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005650\\\/en\\\/1514185\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Congenital Diarrheal Disorders &#8211; Epidemiology Forecast to 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the disease, historical and forecasted Congenital Diarrheal Disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered The United ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-14T15:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220714005650\/en\/1514185\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 &#8211; ResearchAndMarkets.com","datePublished":"2022-07-14T15:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/"},"wordCount":877,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220714005650\/en\/1514185\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/","name":"Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220714005650\/en\/1514185\/21\/logo.jpg","datePublished":"2022-07-14T15:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220714005650\/en\/1514185\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220714005650\/en\/1514185\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-congenital-diarrheal-disorders-epidemiology-forecasts-to-2032-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Congenital Diarrheal Disorders Epidemiology Forecasts to 2032 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46189"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46189\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}